Literature DB >> 25171193

Inhibition of hyperhomocysteinemia-induced inflammasome activation and glomerular sclerosis by NLRP3 gene deletion.

Min Xia1, Sabena M Conley, Guangbi Li, Pin-Lan Li, Krishna M Boini.   

Abstract

BACKGROUND/AIMS: Hyperhomocysteinemia (hHcys) has been reported to initiate Nod-like receptor protein 3 (NLRP3) inflammasome formation and activation in podocytes, leading to glomerular dysfunction and sclerosis. However, it remains unknown whether Nlrp3 gene is critical for the formation and activation of inflammasomes in glomeruli of hHcys mice.
METHODS: Plasma homocysteine concentration was estimated utilizing HPLC, inflammasome formation and immunofluorescence expression from confocal microscopy, IL-1β production from ELISA.
RESULTS: Uninephrectomized Nlrp3 knockout (Nlrp3(-/-)) and wild type (Nlrp3(+/+)) and intra renal Nlrp3 shRNA-transfected wild type mice (Nlrp3 shRNA) were fed a folate free (FF) diet or normal chow (ND) for 4 weeks to produce hHcys. The plasma Hcys levels were significantly elevated in both Nlrp3(-/-) and Nlrp3(+/+) mice fed a FF diet compared to ND fed mice. The FF diet significantly increased the colocalization of Nlrp3 with apoptosis-associated speck-like protein (ASC) or caspase-1, caspase-1 activity and IL-1β production in glomeruli of Nlrp3(+/+), but not in Nlrp3(-/-) mice and local Nlrp3 shRNA transfected mice. Correspondingly, the glomerular damage index (GDI) and urinary protein excretion were significantly higher in Nlrp3(+/+) mice compared to ND fed mice. However, the hHcys-induced increase in GDI and proteinuria were significantly lower in Nlrp3(-/-) and local Nlrp3 shRNA transfected mice than in Nlrp3(+/+) mice. Immunocytochemical analysis showed that hHcys decreased expression of podocin and nephrin, but increased desmin expression in glomeruli of Nlrp3(+/+) mice compared to Nlrp3(-/-) mice.
CONCLUSION: Nlrp3 gene is an essential component of Nlrp3 inflammasomes and that targeting Nlrp3 may be important therapeutic strategy to prevent inflammasome activation and thereby protect podocytes and glomeruli from hHcys-induced injury.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25171193      PMCID: PMC4864609          DOI: 10.1159/000363046

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  57 in total

1.  Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.

Authors:  Chun Zhang; Jun-Jun Hu; Min Xia; Krishna M Boini; Christopher A Brimson; Laura A Laperle; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

2.  Activation of Nod-like receptor protein 3 inflammasomes turns on podocyte injury and glomerular sclerosis in hyperhomocysteinemia.

Authors:  Chun Zhang; Krishna M Boini; Min Xia; Justine M Abais; Xiang Li; Qinglian Liu; Pin-Lan Li
Journal:  Hypertension       Date:  2012-05-29       Impact factor: 10.190

3.  Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.

Authors:  Terry L Lewis; Dongfeng Cao; Hailin Lu; Robert A Mans; Yan Ru Su; Lisa Jungbauer; MacRae F Linton; Sergio Fazio; Mary Jo LaDu; Ling Li
Journal:  J Biol Chem       Date:  2010-09-16       Impact factor: 5.157

Review 4.  Dangers within: DAMP responses to damage and cell death in kidney disease.

Authors:  Diane L Rosin; Mark D Okusa
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

5.  An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney.

Authors:  Hiromi Koike; Naruya Tomita; Haruhito Azuma; Yoshiaki Taniyama; Keita Yamasaki; Yasuo Kunugiza; Katsuro Tachibana; Toshio Ogihara; Ryuichi Morishita
Journal:  J Gene Med       Date:  2005-01       Impact factor: 4.565

Review 6.  NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?

Authors:  Jurg Tschopp; Kate Schroder
Journal:  Nat Rev Immunol       Date:  2010-02-19       Impact factor: 53.106

7.  Ultrasound-based nonviral gene delivery induces bone formation in vivo.

Authors:  D Sheyn; N Kimelman-Bleich; G Pelled; Y Zilberman; D Gazit; Z Gazit
Journal:  Gene Ther       Date:  2007-11-22       Impact factor: 5.250

8.  Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium.

Authors:  Wenjie Wang; Xiangyu Wang; Justin Chun; Akosua Vilaysane; Sharon Clark; Gabrielle French; Nathan A Bracey; Kiril Trpkov; Shirin Bonni; Henry J Duff; Paul L Beck; Daniel A Muruve
Journal:  J Immunol       Date:  2012-12-21       Impact factor: 5.422

9.  Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis.

Authors:  Krishna M Boini; Min Xia; Jing Xiong; Caixia Li; Lori P Payne; Pin-Lan Li
Journal:  J Cell Mol Med       Date:  2012-08       Impact factor: 5.310

10.  Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation.

Authors:  Chuang Wang; Ying Pan; Qing-Yu Zhang; Fu-Meng Wang; Ling-Dong Kong
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

View more
  16 in total

1.  Enhanced epithelial-to-mesenchymal transition associated with lysosome dysfunction in podocytes: role of p62/Sequestosome 1 as a signaling hub.

Authors:  Guangbi Li; Cai-Xia Li; Min Xia; Joseph K Ritter; Todd W B Gehr; Krishna Boini; Pin-Lan Li
Journal:  Cell Physiol Biochem       Date:  2015-03-26

2.  NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury.

Authors:  Guangbi Li; Zhida Chen; Owais M Bhat; Qinghua Zhang; Justine M Abais-Battad; Sabena M Conley; Joseph K Ritter; Pin-Lan Li
Journal:  J Lipid Res       Date:  2017-04-12       Impact factor: 5.922

3.  Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension.

Authors:  Anastasia Familtseva; Pankaj Chaturvedi; Anuradha Kalani; Nevena Jeremic; Naira Metreveli; George H Kunkel; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2016-08-03       Impact factor: 4.249

4.  Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction.

Authors:  Krishna M Boini; Tahir Hussain; Pin-Lan Li; Sai Koka
Journal:  Cell Physiol Biochem       Date:  2017-11-06

5.  Coronary endothelial dysfunction induced by nucleotide oligomerization domain-like receptor protein with pyrin domain containing 3 inflammasome activation during hypercholesterolemia: beyond inflammation.

Authors:  Yang Zhang; Xiang Li; Ashley L Pitzer; Yang Chen; Lei Wang; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-03-31       Impact factor: 8.401

6.  Control of lysosomal TRPML1 channel activity and exosome release by acid ceramidase in mouse podocytes.

Authors:  Guangbi Li; Dandan Huang; Jinni Hong; Owais M Bhat; Xinxu Yuan; Pin-Lan Li
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-03       Impact factor: 4.249

7.  Inhibition of pannexin-1 channel activity by adiponectin in podocytes: Role of acid ceramidase activation.

Authors:  Guangbi Li; Qinghua Zhang; Jinni Hong; Joseph K Ritter; Pin-Lan Li
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-08-01       Impact factor: 4.698

8.  Protective Action of Anandamide and Its COX-2 Metabolite against l-Homocysteine-Induced NLRP3 Inflammasome Activation and Injury in Podocytes.

Authors:  Guangbi Li; Min Xia; Justine M Abais; Krishna Boini; Pin-Lan Li; Joseph K Ritter
Journal:  J Pharmacol Exp Ther       Date:  2016-05-11       Impact factor: 4.030

9.  Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats.

Authors:  Qing Zhu; Xiao-Xue Li; Weili Wang; Junping Hu; Pin-Lan Li; Sabena Conley; Ningjun Li
Journal:  Am J Physiol Renal Physiol       Date:  2016-01-13

Review 10.  Of Inflammasomes and Alarmins: IL-1β and IL-1α in Kidney Disease.

Authors:  Hans-Joachim Anders
Journal:  J Am Soc Nephrol       Date:  2016-08-11       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.